Savara is really a medical-stage biopharmaceutical company developing treatments for unusual respiratory illnesses. Its direct products applicant is really an immunostimulator called molgramostim. Molgramostim is in stage 3 scientific trials to take care of autoimmune pulmonary alveolar proteinosis, or aPAP.That isn’t what I’m most happy with.